GW Pharma

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors
The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors
Motley Fool
GW Pharma
earnings
investors
Flag link:
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Zogenix: Could This Be The Greatest Threat to GW Pharmaceuticals?
Motley Fool
Zogenix
GW Pharma
Sativex
Epidiolex
LGS
Dravet syndrome
Flag link:
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy
Xtalks
GW Pharma
cannabis
clinical trials
Epidiolex
epilepsy
Dravet syndrome
Flag link:
3 Reasons GW Pharmaceuticals Stock Could Rise
3 Reasons GW Pharmaceuticals Stock Could Rise
Motley Fool
GW Pharma
Epidiolex
Flag link:
Top 6 Biopharma Gainers of the Past Week
Top 6 Biopharma Gainers of the Past Week
24/7 Wall St
Catabasis
Sarepta Therapeutics
Anavex
Biogen
Array Biopharma
GW Pharma
Flag link:
3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success
3 for 3 in PhIII: GW Pharma racing to the FDA after bagging another late-stage epilepsy success
Endpoints
GW Pharma
FDA
Epidiolex
epilepsy
Flag link:
Evaluating a GW Pharma Merger, Maybe
Evaluating a GW Pharma Merger, Maybe
Yahoo/24-7
GW Pharma
M&A
Flag link:
GW Pharma spikes as the latest buyout rumors swirl around cannabinoid pipeline
GW Pharma spikes as the latest buyout rumors swirl around cannabinoid pipeline
Endpoints
GW Pharma
cannabis
M&A
Flag link:
GW Pharma to raise $252 mln after cannabis drug success
GW Pharma to raise $252 mln after cannabis drug success
Yahoo/Reuters
GW Pharma
marijuana
Epidiolex
Flag link:
GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal Trial
GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal Trial
TheStreet.com
GW Pharma
marijuana
seizures
clinical trials
epilepsy
Flag link:
Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies
Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies
Yahoo/GuruFocus
Pfizer
Merck
marijuana
GW Pharma
Flag link:
8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls
8 Speculative Biotech and Biohealth Stocks With Major Analyst Upside Calls
24/7 Wall St
GW Pharma
Integra LifeSciences
Minerva Neurosciences
Neurocrine Biosciences
Teladoc
TG Therapeutics
Asterias
Innocoll GmbH
Flag link:
5 Major Clinical Trial Results Coming Up
5 Major Clinical Trial Results Coming Up
24/7 Wall St
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04
Flag link:
4 Top Stocks in the Growing Medical Marijuana Industry
4 Top Stocks in the Growing Medical Marijuana Industry
TheStreet.com
Medical Marijuana
AbbVie
Cara Therapeutics
GW Pharma
INSYS Therapeutics
Flag link:
8 Major Biopharma Events Coming Later in 2016 and in 2017
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Vertex Pharmaceuticals
VX-661
cystic fibrosis
Incyte
ruxolitinib
colorectal cancer
breast cancer
Ultragenyx
KRN23
osteomalacia
GW Pharma
Epidiolex
Puma Biotechnology
neratinib
Celator Pharmaceuticals
Vyxeos
Biocryst
OPuS-2
BCX7353
HAE
Galena Biopharma
NeuVax
trastuzumab
Flag link:
Why GW Pharma Could More Than Double From Cannabinoid Drugs
Why GW Pharma Could More Than Double From Cannabinoid Drugs
24/7 Wall St
GW Pharma
Medical Marijuana
Flag link:
4 Key Biopharma Movers of the Past Week
4 Key Biopharma Movers of the Past Week
24/7 Wall St
GW Pharma
Celator
Bio Blast Pharma
Vitae
Flag link:
GW Pharmaceuticals' Marijuana-Based Drug Hits the Mark in Pivotal-Stage Study
GW Pharmaceuticals' Marijuana-Based Drug Hits the Mark in Pivotal-Stage Study
Motley Fool
GW Pharma
marijuana
epilepsy
anti-seizure
Epidiolex
Flag link:
5 Biotech Predictions for 2016
5 Biotech Predictions for 2016
Motley Fool
biotech
GW Pharma
Medical Marijuana
Big Pharma
Alzheimer's disease
CAR-T
Portola Pharmaceuticals
Eli Lilly
Biogen
Axovant Sciences
Flag link:
2015's Worst Clinical Failures
2015's Worst Clinical Failures
Motley Fool
clinical trials
liver disease
cancer pain
Eli Lilly
Intercept Pharmaceuticals
GW Pharma
Flag link: